#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	15942	16S	1529	1529	100.0	16S.l15.c4.ctg.1	2138	734.8	1	SNP	n	C1184T	0	.	.	1184	1184	C	1468	1468	C	889	C,G	852,2	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	15942	16S	1529	1529	100.0	16S.l15.c4.ctg.1	2138	734.8	0	HET	.	.	.	C451T,A	.	451	451	C	735	735	C	918	C,T,A	649,224,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	28836	23S	2890	2890	99.93	23S.l15.c30.ctg.1	3832	747.6	0	.	n	.	0	T695C	SNP	695	695	T	1108	1108	C	934	C	893	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	28836	23S	2890	2890	99.93	23S.l15.c30.ctg.1	3832	747.6	0	.	n	.	0	T1971C	SNP	1971	1971	T	2384	2384	C	919	C,G	871,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	28836	23S	2890	2890	99.93	23S.l15.c30.ctg.1	3832	747.6	1	SNP	n	A2045G	0	.	.	2045	2045	A	2458	2458	A	957	A	915	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	28836	23S	2890	2890	99.93	23S.l15.c30.ctg.1	3832	747.6	1	SNP	n	C2597T	0	.	.	2597	2597	C	3010	3010	C	846	C	814	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	28836	23S	2890	2890	99.93	23S.l15.c30.ctg.1	3832	747.6	0	HET	.	.	.	A1638G	.	1638	1638	A	2051	2051	A	911	A,G	467,410	.	.
folP.WHO_O_01412c	folP.WHO_O_01412c	1	1	27	2132	folP	855	855	100.0	folP.l15.c4.ctg.1	1622	130.2	1	SNP	p	R229S	1	.	.	685	687	AGC	1079	1081	AGC	221;222;221	A;G;C	212;213;211	folP.WHO_O_01412c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5950	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3468	170.3	1	SNP	p	S91F	1	.	.	271	273	TTC	593	595	TTC	200;204;204	T;T;C	189;190;189	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5950	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3468	170.3	1	SNP	p	G95N	0	.	.	283	285	GGC	605	607	GGC	197;199;200	G;G;C,G	183;187;186,1	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5950	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3468	170.3	1	SNP	p	D95G	1	.	.	283	285	GGC	605	607	GGC	197;199;200	G;G;C,G	183;187;186,1	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
mtrR.WHO_O_01438	mtrR.WHO_O_01438	1	1	27	1724	mtrR	633	633	100.0	mtrR.l15.c30.ctg.1	1528	112.0	1	SNP	p	G45D	0	.	.	133	135	GGC	531	533	GGC	229;227;228	G;G;C	218;215;218	mtrR.WHO_O_01438:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	940	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c30.ctg.1	1096	85.4	0	.	n	.	0	A197.	DEL	197	197	A	601	601	A	231	A	223	.	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5942	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2953	199.2	1	SNP	p	D86N	0	.	.	256	258	GAC	602	604	GAC	220;220;221	G;A;C	207;206;212	parC.WHO_Y_00247c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5942	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2953	199.2	1	SNP	p	R87I	0	.	.	259	261	CGT	605	607	CGT	226;228;227	C;G;T	219;217;211	parC.WHO_Y_00247c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5942	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2953	199.2	1	SNP	p	S87R	1	.	.	259	261	CGT	605	607	CGT	226;228;227	C;G;T	219;217;211	parC.WHO_Y_00247c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5942	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2953	199.2	1	SNP	p	R87W	0	.	.	259	261	CGT	605	607	CGT	226;228;227	C;G;T	219;217;211	parC.WHO_Y_00247c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5942	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2953	199.2	1	SNP	p	S88P	0	.	.	262	264	TCC	608	610	TCC	229;229;231	T;C;C	218;216;218	parC.WHO_Y_00247c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	4378	parE	1986	1986	100.0	parE.l6.c4.ctg.1	2679	161.7	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1576	1578	GGC	264;264;263	G;G;C	246;247;240	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.34.001	penA.34.001	1	1	27	4042	penA	1746	1746	100.0	penA.l6.c4.ctg.1	2359	169.6	1	SNP	p	A311V	0	.	.	931	933	GCC	1245	1247	GCC	206;207;208	G;C,T;C,G	191;192,1;194,1	penA.34.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4042	penA	1746	1746	100.0	penA.l6.c4.ctg.1	2359	169.6	1	SNP	p	I312M	1	.	.	934	936	ATG	1248	1250	ATG	211;210;212	A;T;G,A	199;194;196,1	penA.34.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4042	penA	1746	1746	100.0	penA.l6.c4.ctg.1	2359	169.6	1	SNP	p	T316P	0	.	.	946	948	ACC	1260	1262	ACC	206;203;206	A;C;C	190;192;195	penA.34.001:1:1:T316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4042	penA	1746	1746	100.0	penA.l6.c4.ctg.1	2359	169.6	1	SNP	p	V316T	1	.	.	946	948	ACC	1260	1262	ACC	206;203;206	A;C;C	190;192;195	penA.34.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4042	penA	1746	1746	100.0	penA.l6.c4.ctg.1	2359	169.6	1	SNP	p	T483S	0	.	.	1447	1449	ACC	1761	1763	ACC	221;222;224	A;C;C	204;212;214	penA.34.001:1:1:T483S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4042	penA	1746	1746	100.0	penA.l6.c4.ctg.1	2359	169.6	1	SNP	p	A501P	0	.	.	1501	1503	GCG	1815	1817	GCG	193;192;194	G;C,T;G	186;183,1;187	penA.34.001:1:1:A501P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4042	penA	1746	1746	100.0	penA.l6.c4.ctg.1	2359	169.6	1	SNP	p	A501V	0	.	.	1501	1503	GCG	1815	1817	GCG	193;192;194	G;C,T;G	186;183,1;187	penA.34.001:1:1:A501V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4042	penA	1746	1746	100.0	penA.l6.c4.ctg.1	2359	169.6	1	SNP	p	G542S	0	.	.	1624	1626	GGT	1938	1940	GGT	169;166;168	G;G;T	162;156;157	penA.34.001:1:1:G542S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4042	penA	1746	1746	100.0	penA.l6.c4.ctg.1	2359	169.6	1	SNP	p	G545S	1	.	.	1633	1635	AGC	1947	1949	AGC	152;151;151	A;G;C	141;143;143	penA.34.001:1:1:G545S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4042	penA	1746	1746	100.0	penA.l6.c4.ctg.1	2359	169.6	1	SNP	p	P551S	0	.	.	1651	1653	CCG	1965	1967	CCG	142;146;147	C,G;C;G	109,8;112;112	penA.34.001:1:1:P551S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	6352	ponA	2397	2397	100.0	ponA.l6.c30.ctg.1	3233	194.9	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1673	1675	CCG	206;208;211	C;C;G	191;195;192	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2574	porA	1146	1146	99.91	porA.l15.c17.ctg.1	1927	132.6	0	.	p	.	0	M83fs	FSHIFT	247	247	A	560	560	C	182	C	172	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	27	3160	porB1b	1038	1038	100.0	porB1b.l15.c4.ctg.1	1549	201.8	1	SNP	p	G120K	1	.	.	358	360	AAG	656	658	AAG	257;258;257	A;A;G	246;248;247	porB1b.WHO_Y_02277c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	27	3160	porB1b	1038	1038	100.0	porB1b.l15.c4.ctg.1	1549	201.8	1	SNP	p	A121N	1	.	.	361	363	AAC	659	661	AAC	259;258;259	A,G;A;C	248,1;247;247	porB1b.WHO_Y_02277c:1:1:A121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	27	3160	porB1b	1038	1038	100.0	porB1b.l15.c4.ctg.1	1549	201.8	1	SNP	p	N121D	0	.	.	361	363	AAC	659	661	AAC	259;258;259	A,G;A;C	248,1;247;247	porB1b.WHO_Y_02277c:1:1:N121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	11602	rpoB	4179	4179	99.98	rpoB.l15.c17.ctg.1	4765	240.9	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1378	rpsJ	312	312	100.0	rpsJ.l6.c4.ctg.1	1041	130.5	1	SNP	p	V57M	1	.	.	169	171	ATG	535	537	ATG	274;271;270	A;T;G	263;259;259	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
